Pi Industries Limited · NSE:PIIND

Pi Industries — Investor Presentation (March 2016)

28 slides from Pi Industries's investor presentation, March 2016

  1. Slide 1: PI Industries Ltd. Investor Presentation March, 2016

    PI Industries Ltd. Investor Presentation March, 2016

  2. Slide 2: Disclaimer

    Disclaimer Certain statements made in this presentation may not be based on historical information or facts and may be “forward looking statements,” including those relating to general business plans and strategy of PI Industries Limited (“PIIL"), its future outlook and growth prospects, and future

  3. Slide 3: Table of Contents

    Table of Contents 1. Introduction to PI Industries 2. Key Strengths of the Company 3. Business Strategy 4. Financial Overview 5. Annexure: Industry 6. Annexure: Custom Synthesis Manufacturing Processes 3

  4. Slide 4: Introduction To PI Industries

    Introduction To PI Industries 4

  5. Slide 5: PI Industries: Overview

    PI Industries: Overview Overview • Incorporated in 1947, PI Industries Limited is an Agri Input and Custom Synthesis & Manufacturing company in India • Multi‐locational manufacturing facilities, including Jambusar SEZ • Equipped with R&D facilities, accredited for GLP and ‘Norms on OECD Principles’

  6. Slide 6: Key Milestones

    Key Milestones  Commenced  Accredited by commercial OHSAS 18001 and  Accredited with production at ISO 17025 GLP newly  Established PI Life  Inauguration of PI- commissioned unit  Diversified in  Commenced Sciences Research Sony Research at Jambusar SEZ Energy Metering commercial Ltd. Center

  7. Slide 7: Domestic Business: Agri-inputs

    Domestic Business: Agri-inputs AGRI INPUTS – AGRO CHEMICALS, SPECIALTY FERTILIZERS & Activities under Agri input PLANT NUTRIENTS • In‐licensing of newly launched or patented molecules • Developed brand recognition and a pan‐India from multinational innovators to register, formulate and distribution

  8. Slide 8: Exports Business: Custom Synthesis

    Exports Business: Custom Synthesis CUSTOM SYNTHESIS AND CONTRACT MANUFACTURING: Scope of Services FINE CHEMICALS • Contract research, process development, analytical • Provides contract research and contract method development manufacturing services • Wide end use segments across global agrochemical

  9. Slide 9: Solid Infrastructure Setup

    Solid Infrastructure Setup • Multi‐locational manufacturing facilities – 5 Multi‐product plants and 2 Formulation units in Panoli spread over 79,000 sq. mtr. – 3 Multi‐product plants in Jambhusar with ample scope for expansion 88,000 sq. mtr. • Manufacturing facilities are ISO 9001, ISO 14001, OHSAS

  10. Slide 10: Key Strengths

    Key Strengths 10

  11. Slide 11: Key Strengths

    Key Strengths Long-term Relationship & reputation of trust and reliability with global innovators Brand building Experienced capabilities and brand management team recognition Differentiated business model Wide distribution Entry / exit network and clear barriers in our distribution policies busines

  12. Slide 12: Key Strengths (1/7) Differentiated business model

    Key Strengths (1/7) 1 Differentiated business model 3/2/2016 Project name 12

  13. Slide 13: Key Strengths (2-3/7)

    Key Strengths (2-3/7) 2 Long-term Relationship and reputation of trust and reliability with global innovators 3 Brand building capabilities and brand recognition • Bayer Group of Companies awarded Certificate of Excellence to PI Industries As “Winner – Global Sourcing India 2013 • PI Industries rece

  14. Slide 14: Key Strengths (4/7) Wide distribution network and clear distribution policies

    Key Strengths (4/7) 4 Wide distribution network and clear distribution policies Distribution Network • 29 branches • 10,000+ distributors / dealer • Centralized SAP based ERP system which gives us efficient last-mile connectivity Clear Distribution Policies that minimize dispute • Provide delivery o

  15. Slide 15: Key Strengths (5/7) End-to-end Capabilities in custom synthesis

    Key Strengths (5/7) 5 End-to-end Capabilities in custom synthesis 3/2/2016 Project Custom Synthesis is a key growth driver: Gives visibility for name top line growth & assures long term sustainability for margins 15

  16. Slide 16: Key Strengths (6/7) Entry / Exit barriers in our business

    Key Strengths (6/7) 6 Entry / Exit barriers in our business Entry barriers for Domestic Agri input activity Exit barriers for Export Custom synthesis activity • Early and close working relationship with • Registration process in India requires global innovators which allow us to generate substantial

  17. Slide 17: Key Strengths (7/7) Experienced Board & Management Team

    Key Strengths (7/7) 7 Experienced Board & Management Team • Professionally managed Company with a board of directors consisting of individuals with backgrounds across various industries & disciplines like agro‐chemicals industry, pharmaceuticals industry and financial services and accounting discipl

  18. Slide 18: Key Strengths (7/7)

    Key Strengths (7/7) P K Lahiri Mr. Pravin K. Laheri (IAS Retd.) Gujarat cadre studied at St. Xavier’s College and Government Law College, Mumbai. Mr. P.K. Laheri joined Indian Railways in 1967 and Indian Administrative Services in 1969. He served in Government Independent Director of Gujarat in vari

  19. Slide 19: Business Strategy

    Business Strategy 19

  20. Slide 20: Business Strategy

    Business Strategy Focus on expanding • Expand product portfolio of agri input products, with primary focus on in‐licensing arrangements and co‐marketed products our product portfolio • Expand existing chemistries to all existing customers for export custom and service offerings synthesis segment • I

  21. Slide 21: Financial Overview

    Inspired by Science C) @\ O5 OO.

  22. Slide 22: Growth Profile

    Growth Profile Gross Revenues Rs. Cr 3000 2185 1837 2000 1310 Improved business mix drives 1000 834 999 27% CAGR topline growth 0 FY11 FY12 FY13 FY14 FY15 EBITDA Rs. Cr. 370 400 286 300 Focus on in-licensed products in 179 domestic business and high- 200 114 141 34% CAGR potential molecules in expor

  23. Slide 23: Margin Profile

    Margin Profile EBITDA in Rs. Cr. & Margins 25.0% 19.1% 400 20.0% 17.2% 18.0% 17.9% 15.6% 300 15.0% EBITDA margins driven by 200 10.0% enhancement to business mix and 5.0% 100 operating leverage 114 141 179 286 370 0.0% 0 FY11 FY12 FY13 FY14 FY15 EBITDA in Rs. Cr. & Margins (season-wise) 200 19.7% 20

  24. Slide 24: Enhancing Shareholder Value

    Enhancing Shareholder Value ROCE in % RONW in % Div. Payout Ratio in % 40.0 37.9 35.0 20.0 35.0 16.2 17.0 16.0 35.0 30.0 32.0 31.8 16.0 14.1 30.0 25.0 28.7 27.1 22.7 23.6 23.2 12.0 25.0 20.0 9.0 18.3 20.0 15.0 8.0 FY11 FY12 FY13 FY14 FY15 FY11 FY12 FY13 FY14 FY15 FY11 FY12 FY13 FY14 FY15 ROBUST TREN

  25. Slide 25: Driving Quality Operations

    Driving Quality Operations Long Term Debt Equity Ratio Asset Turnover Ratio No. of WC days 0.60 90.9 0.45 2.40 95.0 85.3 0.37 2.11 2.13 2.10 85.0 0.40 2.10 1.96 75.0 68.0 0.16 1.74 65.0 56.0 0.20 0.07 1.80 52.0 0.02 55.0 0.00 1.50 45.0 FY11 FY12 FY13 FY14 FY15 FY11 FY12 FY13 FY14 FY15 FY11 FY12 FY13

  26. Slide 26: Key Financial Highlights

    Key Financial Highlights Q3 FY16 Growth (%) 9M FY16 Growth (%) (Rs. in Crore) (Y-o-Y) (Rs. in Crore) (Y-o-Y) Revenues 511.0 1% 1,511.9 8% EBITDA 104.8 11% 325.4 18% PAT 72.5 17% 218.1 19% Results analysis Net Revenues Revenue growth in 9M FY16 stood at 8% driven by 3% growth in domestic agri-input a

  27. Slide 27: Outlook

    Outlook • The global agro chemical industry is going through a challenging environment. The domestic markets have also seen a slowdown in last couple of seasons due to poor agro climatic conditions. However, PI’s outlook for the medium and long term remains robust due to the following factors: • Gro

  28. Slide 28: Thank You

    THANK YOU CIN: L24211RJ1946PLC000469 PI Industries Ltd. Regd. Off.: Udaisagar Road, Udaipur – 313001 (Raj), India, Tel: + 91 294 2492451, Fax: +91 2491946 Corporate Off.: 5th floor, Vipul Square,B Block, Sushant Lok,Phase - 1, Gurgaon 28 www.piindustries.com

PI Industries — Investor Presentation (March 2016) on 6ix